Trexquant Investment’s Vaxcyte PCVX Stock Holding History

Trexquant Investment’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.46M	Buy	128,333 +79,121	+161%	+$4.3M	0.04%	562
2026 Q1	$2.86M	Buy	+49,212	New	+$2.67M	0.02%	859
2025 Q4	–	Sell	-119,850	Closed	-$4.32M	–	1842
2025 Q3	$4.32M	Buy	119,850 +13,569	+13%	+$450K	0.04%	605
2025 Q2	$3.46M	Buy	+106,281	New	+$3.48M	0.04%	673
2025 Q1	–	Sell	-66,249	Closed	-$5.42M	–	1788
2024 Q4	$5.42M	Sell	66,249 -13,689	-17%	-$1.36M	0.06%	500
2024 Q3	$9.13M	Buy	+79,938	New	+$7.2M	0.12%	265
2023 Q4	–	Sell	-43,329	Closed	-$2.21M	–	1699
2023 Q3	$2.21M	Buy	43,329 +38,058	+722%	+$1.88M	0.06%	461
2023 Q2	$263K	Sell	5,271 -33,893	-87%	-$1.61M	0.01%	1235
2023 Q1	$1.47M	Buy	39,164 +22,559	+136%	+$957K	0.04%	573
2022 Q4	$796K	Buy	+16,605	New	+$652K	0.02%	735
2022 Q3	–	Sell	-16,851	Closed	-$367K	–	1735
2022 Q2	$367K	Buy	+16,851	New	+$390K	0.02%	1013

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Trexquant Investment's PCVX Position: Q2 2026 in Review

Trexquant Investment increased its Vaxcyte (PCVX) stake by 161% in Q2 2026, buying an estimated $4.3M and bringing the position to 128,333 shares worth $7.46M. The position accounts for 0.04% of the portfolio, ranked #562.

Trexquant Investment first reported a position in PCVX in Q2 2022 and has held it in 11 quarters since. The position peaked at $9.13M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Trexquant Investment held 128,333 shares of Vaxcyte worth $7.46M as of Q2 2026.
Trexquant Investment bought 79,121 Vaxcyte shares in Q2 2026, an estimated $4.3M.
Vaxcyte made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #562 holding.
Trexquant Investment first reported a position in Vaxcyte in Q2 2022 and has held it in 11 quarters since.
Trexquant Investment's Vaxcyte position peaked at $9.13M in Q3 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.